Advertisement
BrainsWay Ltd.

BrainsWay Ltd. (BWAY) Stock Overview

Explore BrainsWay Ltd.โ€™s financial performance, market position, analyst ratings, and future outlook.

BWAYโ—NASDAQ
HealthcareMedical - Devices
$14.70
$0.29(1.98%)
U.S. Market is Open ยท 12:16
Advertisement

BrainsWay Ltd. (BWAY)

Meyka AI Score

Z

Key Financials

Market Cap566M
P/E Ratio30.63
EPS (TTM)$0.22
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

BWAY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BrainsWay Ltd. (BWAY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 39.93, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 30.63 and a market capitalization of 566M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.94%
5-Day Change
-1.19%
1-Month Change
-17.59%
3-Month Change
11.33%
6-Month Change
58.10%
Year-to-Date (YTD) Change
48.79%
1-Year Change
146.95%
3-Year Change
1163.39%
5-Year Change
143.55%
All-Time (Max) Change
154.95%

Contact Information

972 2 582 4030
Bynet Building, Jerusalem, NaN, 9777518

Company Facts

120 Employees
IPO DateApr 17, 2019
CountryIL
Actively Trading

Frequently Asked Questions